Annual FCF
-$48.66 M
-$4.42 M-10.00%
December 31, 2021
Summary
- As of February 10, 2025, GNCA annual free cash flow is -$48.66 million, with the most recent change of -$4.42 million (-10.00%) on December 31, 2021.
- During the last 3 years, GNCA annual FCF has fallen by -$7.18 million (-17.32%).
Performance
GNCA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$16.17 M
-$4.13 M-34.30%
March 31, 2022
Summary
- As of February 10, 2025, GNCA quarterly free cash flow is -$16.17 million, with the most recent change of -$4.13 million (-34.30%) on March 31, 2022.
- Over the past year, GNCA quarterly FCF has dropped by -$2.67 million (-19.76%).
Performance
GNCA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$51.33 M
-$2.67 M-5.48%
March 31, 2022
Summary
- As of February 10, 2025, GNCA TTM free cash flow is -$51.33 million, with the most recent change of -$2.67 million (-5.48%) on March 31, 2022.
- Over the past year, GNCA TTM FCF has dropped by -$7.62 million (-17.43%).
Performance
GNCA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
GNCA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.0% | -19.8% | -17.4% |
| 3 y3 years | -17.3% | -53.7% | -32.0% |
| 5 y5 years | +0.2% | -8.2% | -32.0% |
GNCA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +34.3% | at low | +5.5% | at low |
| 5 y | 5-year | +25.2% | at low | +80.4% | at low | +32.0% | at low |
| alltime | all time | +270.3% | +0.2% | +305.7% | at low | +851.7% | +3.2% |
Genocea Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$16.17 M(+34.3%) | -$51.33 M(+5.5%) |
| Dec 2021 | -$48.66 M(+10.0%) | -$12.04 M(+1.3%) | -$48.66 M(+2.2%) |
| Sep 2021 | - | -$11.89 M(+5.9%) | -$47.63 M(+6.6%) |
| Jun 2021 | - | -$11.23 M(-16.9%) | -$44.70 M(+2.3%) |
| Mar 2021 | - | -$13.50 M(+22.6%) | -$43.71 M(-1.2%) |
| Dec 2020 | -$44.24 M(+13.8%) | -$11.01 M(+22.9%) | -$44.24 M(+4.4%) |
| Sep 2020 | - | -$8.96 M(-12.4%) | -$42.35 M(-4.9%) |
| Jun 2020 | - | -$10.23 M(-27.1%) | -$44.53 M(+5.1%) |
| Mar 2020 | - | -$14.03 M(+53.6%) | -$42.38 M(+9.0%) |
| Dec 2019 | -$38.87 M(-6.3%) | -$9.13 M(-18.0%) | -$38.87 M(+2.4%) |
| Sep 2019 | - | -$11.14 M(+38.0%) | -$37.94 M(+3.9%) |
| Jun 2019 | - | -$8.08 M(-23.2%) | -$36.52 M(-6.0%) |
| Mar 2019 | - | -$10.52 M(+28.2%) | -$38.86 M(-6.3%) |
| Dec 2018 | -$41.48 M(-15.0%) | -$8.21 M(-15.6%) | -$41.48 M(+0.2%) |
| Sep 2018 | - | -$9.72 M(-6.7%) | -$41.37 M(-5.1%) |
| Jun 2018 | - | -$10.42 M(-20.7%) | -$43.59 M(-7.2%) |
| Mar 2018 | - | -$13.13 M(+62.1%) | -$46.97 M(-3.7%) |
| Dec 2017 | -$48.78 M | -$8.10 M(-32.1%) | -$48.78 M(-7.9%) |
| Sep 2017 | - | -$11.94 M(-13.5%) | -$52.98 M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$13.79 M(-7.7%) | -$51.69 M(+6.4%) |
| Mar 2017 | - | -$14.94 M(+21.5%) | -$48.56 M(+9.4%) |
| Dec 2016 | -$44.37 M(+7.8%) | -$12.30 M(+15.5%) | -$44.37 M(+3.2%) |
| Sep 2016 | - | -$10.65 M(-0.2%) | -$42.99 M(+3.6%) |
| Jun 2016 | - | -$10.67 M(-0.8%) | -$41.50 M(+1.4%) |
| Mar 2016 | - | -$10.76 M(-1.5%) | -$40.92 M(-0.5%) |
| Dec 2015 | -$41.14 M(+41.3%) | -$10.92 M(+19.3%) | -$41.14 M(+5.7%) |
| Sep 2015 | - | -$9.15 M(-9.2%) | -$38.92 M(+5.1%) |
| Jun 2015 | - | -$10.09 M(-8.1%) | -$37.02 M(+10.4%) |
| Mar 2015 | - | -$10.98 M(+26.3%) | -$33.54 M(+15.2%) |
| Dec 2014 | -$29.12 M(+43.7%) | -$8.70 M(+19.8%) | -$29.12 M(+8.5%) |
| Sep 2014 | - | -$7.26 M(+9.9%) | -$26.84 M(+13.9%) |
| Jun 2014 | - | -$6.61 M(+0.7%) | -$23.56 M(+9.9%) |
| Mar 2014 | - | -$6.56 M(+2.4%) | -$21.43 M(+5.8%) |
| Dec 2013 | -$20.26 M(+54.2%) | -$6.41 M(+60.7%) | -$20.26 M(+46.2%) |
| Sep 2013 | - | -$3.99 M(-10.9%) | -$13.86 M(+40.4%) |
| Jun 2013 | - | -$4.48 M(-17.0%) | -$9.87 M(+83.0%) |
| Mar 2013 | - | -$5.39 M | -$5.39 M |
| Dec 2012 | -$13.14 M(-4.8%) | - | - |
| Dec 2011 | -$13.81 M | - | - |
FAQ
- What is Genocea Biosciences annual free cash flow?
- What is the all time high annual FCF for Genocea Biosciences?
- What is Genocea Biosciences annual FCF year-on-year change?
- What is Genocea Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Genocea Biosciences?
- What is Genocea Biosciences quarterly FCF year-on-year change?
- What is Genocea Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Genocea Biosciences?
- What is Genocea Biosciences TTM FCF year-on-year change?
What is Genocea Biosciences annual free cash flow?
The current annual FCF of GNCA is -$48.66 M
What is the all time high annual FCF for Genocea Biosciences?
Genocea Biosciences all-time high annual free cash flow is -$13.14 M
What is Genocea Biosciences annual FCF year-on-year change?
Over the past year, GNCA annual free cash flow has changed by -$4.42 M (-10.00%)
What is Genocea Biosciences quarterly free cash flow?
The current quarterly FCF of GNCA is -$16.17 M
What is the all time high quarterly FCF for Genocea Biosciences?
Genocea Biosciences all-time high quarterly free cash flow is -$3.99 M
What is Genocea Biosciences quarterly FCF year-on-year change?
Over the past year, GNCA quarterly free cash flow has changed by -$2.67 M (-19.76%)
What is Genocea Biosciences TTM free cash flow?
The current TTM FCF of GNCA is -$51.33 M
What is the all time high TTM FCF for Genocea Biosciences?
Genocea Biosciences all-time high TTM free cash flow is -$5.39 M
What is Genocea Biosciences TTM FCF year-on-year change?
Over the past year, GNCA TTM free cash flow has changed by -$7.62 M (-17.43%)